Isonga ryiza rya Glybenzcyclamide Hagati ya Synthesis ya Pharmaceutical

Muri Jiangsu Jingye Pharmaceutical Co., Ltd., twishimiye kuba umufatanyabikorwa wizewe mu rwego rwo gutanga imiti ku isi. Nkumushinga wihariye wibikoresho bya farumasi nabahuza, twumva uruhare rukomeye ibyoGlybenzcyclamide IntermediatesGira uruhare mu guteza imbere ibiyobyabwenge no kubyaza umusaruro-cyane cyane mu kuvura diyabete yo mu bwoko bwa 2.

Ntabwo dukora imiti gusa. Dutanga ubwizerwe, ubuziranenge, n'amahoro yo mumutima mubigo bikorerwamo ibya farumasi kwisi.

Impamvu abahuza bacu ba Glybenzcyclamide bahagaze neza

Abahuza ba Glybenzcyclamide nibintu byingenzi muguhuza imiti ya sulfonylurea yo mu rwego rwo kurwanya diyabete, harimo na Glibenclamide. Ubwiza bwaba bahuza bugira ingaruka itaziguye kumikorere numutekano wibicuruzwa byanyuma.

Kuri Pharmaceutical ya Jiangsu Jingye, hagati yacu-4- (2-aminoethyl) benzenesulfonamide-ikorerwa muri protocole igenzura ubuziranenge. Ihora yujuje amahame akurikira:

Isuku ≥99%, yemejwe nubuhanga buhanitse bwo gusesengura (HPLC, GC, NMR)

Iterambere ryiza kandi rihamye, ndetse no mubice byinshi byakozwe

Inkunga yuzuye yubuyobozi, harimo COA, MSDS, hamwe namakuru yatunganijwe

Isoko ryoroshye rya R&D, indege, hamwe nubucuruzi busabwa

Muguhitamo Glybenzcyclamide Intermediates, abakiriya bacu bungukirwa no guhuza neza, kunanirwa gake, hamwe nurufatiro rukomeye rwo kugenzura.

Guhanga udushya biri muri ADN yacu

Ikigo cyacu gifite ibikoresho bigezweho kandi bikoreshwa nitsinda ryabahanga batojwe. Turakomeza kunonosora inzira zacu kugirango tumenye neza ko abahuza bacu bujuje ibyifuzo byinganda zimiti.

Ntabwo duhagarara kubyo twiteze - turabarenze. Murugo rwacu R&D iraduha gutanga synthèse yihariye hamwe ninama zo guhitamo kubakiriya bashaka ibisubizo byihariye. Waba urimo gukora verisiyo rusange cyangwa gukora molekile nshya yibiyobyabwenge, turashobora gutera inkunga ikipe yawe hamwe na Glybenzcyclamide Intermediates.

Utanga isoko Urashobora Kwizera

Mu myaka yashize, twubatse umubano ukomeye n’amasosiyete yimiti mu Burayi, Aziya, na Amerika. Abafatanyabikorwa bacu ku isi batwishingikiriza kuri:

Gutanga ku gihe, ndetse no mugihe ntarengwa

Ibiciro birushanwe, utabangamiye ubuziranenge

Itumanaho ryitabira, hamwe nubufasha bwuzuye bwa tekiniki nubuyobozi

Umwe mu bakiriya bacu b'Abanyaburayi, uruganda rukora ibiyobyabwenge ruciriritse, yazamuye umusaruro wa 18% nyuma yo kwimukira muri Glybenzcyclamide Intermediates. Ibi byahinduwe muburyo bwo kuzigama buri mwaka amadolari arenga 200.000 kandi byagabanije cyane raporo zitandukanya amabwiriza.

Twizera ko aribwo ubufatanye nyabwo busa: gukura hagati gushingiye ku kwizerana no gukora.

Ushinzwe Gukora Isi Nziza

Nka sosiyete ikora imiti, twumva inshingano zacu kubarwayi ndetse nisi. Ibikoresho byacu byo gukora byujuje ubuziranenge bwa GMP, ISO9001, na REACH. Twongeyeho, tugira uruhare rugaragara muri gahunda ya chimie yicyatsi, tugamije kugabanya imyanda n’ingaruka ku bidukikije kuri buri cyiciro cyibikorwa byacu.

Imyitwarire yacu yemeza ko buri cyiciro cya Glybenzcyclamide Intermediates cyakozwe neza, byemewe n'amategeko, kandi birambye.

Korana natwe

Twebwe muri Jiangsu Jingye Pharmaceutical Co., Ltd. ntabwo turenze gutanga gusa Glybenzcyclamide Intermediates. Turi abafatanyabikorwa bawe mugukora imiti itekanye, ikora neza. Kuva ku isuku ryinshi kugeza kubintu byizewe no kubahiriza amabwiriza, dutanga ubuziranenge utegereje - na serivisi ukwiye.

Sura urubuga rwacu kugirango umenye byinshi kubo turibo, cyangwa ushakishe ibicuruzwa byacu byihariye, 4- (2-aminoethyl) benzenesulfonamide, kugirango urebe uburyo dushobora gushyigikira formulaire yawe itaha.

Reka twubake ejo hazaza h'udushya twa farumasi - hamwe.